CompletedEUCTR 2008-001718-26
An eight-week, multicenter, randomized, double-blind, placebo-controlled dose-finding study, with escitalopram (10mg daily) as active control, to evaluate the efficacy, safety and tolerability of t...
This historical record does not confirm current site availability.
Historical research recordSlovakiaDepression
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Slovakia
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- 500
- Sponsor
- Sanofi-Aventis Recherche & Développement
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Slovakia
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2008-001718-26
- Official title
Show the full official title
An eight-week, multicenter, randomized, double-blind, placebo-controlled dose-finding study, with escitalopram (10mg daily) as active control, to evaluate the efficacy, safety and tolerability of t...
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedSlovakia
Registry details
Historical country statuses
- Slovakia — Completed
Questions about this study
Who is behind this study?
The study sponsor is Sanofi-Aventis Recherche & Développement.
